2 Citations
Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
- Biology, PsychologyCells
- 2021
This study aims to review emerging evidence that provide mechanistic insights between different CNS disorders, neuroinflammation and the kynurenine pathway pertinent to CNS disease pathology that have therapeutic implications for the development of selected and efficacious treatment strategies.
C-reactive protein in patients with major depressive disorder in Zagazig university hospitals.
- Psychology, MedicineZagazig University Medical Journal
- 2019
CRP was elevated in patients with MDD and associated with severity of MDD, which supports the previous findings that inflammatory hypothesis has a great role in major depressive disorder pathogenesis.
References
SHOWING 1-10 OF 187 REFERENCES
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
- BiologyCurrent neuropharmacology
- 2015
Novel targets for major depressive disorder are discussed to describe their potential mechanisms of action, the available clinical evidence for these targets, the limitations of available evidence as well as future research directions.
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
- Biology, PsychologyExpert review of clinical pharmacology
- 2017
Of these novel targets, the most promising – and the ones for whom the most evidence exists – appear to be the ionotropic glutamate receptors, which will require health professionals to pre-emptively identify potential responders.
Emerging role of glutamate in the pathophysiology of major depressive disorder
- Biology, PsychologyBrain Research Reviews
- 2009
Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology
- PsychologyMolecular Psychiatry
- 2004
It is proposed that therapeutics designed to enhance cellular plasticity and resilience and that counter maladaptive stress-responsive systems may have considerable utility for the treatment of bipolar disorder.
The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
- Psychology, BiologyMolecular Psychiatry
- 2013
Current knowledge of the neuroprogressive processes that may occur in MDD is reviewed, including structural brain consequences and potential molecular mechanisms including the role of neurotransmitter systems, inflammatory, oxidative and nitrosative stress pathways, neurotrophins and regulation of neurogenesis, cortisol and the hypothalamic–pituitary–adrenal axis modulation.
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development
- Psychology, BiologyThe Australian and New Zealand journal of psychiatry
- 2013
Converting data implicate mitochondrial dysfunction as an important component of the pathophysiology of bipolar disorder and clinical trials of individual MMs as well as combinations are warranted.
The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.
- Psychology, MedicineThe Journal of clinical psychiatry
- 2014
Being negative at the week 12 end point, and with some positive secondary signals, the study provides only limited support for the role of NAC as a novel adjunctive therapy for MDD, although definitive confirmation remains necessary.
Novel therapeutic targets in depression: Minocycline as a candidate treatment
- Psychology, BiologyBehavioural Brain Research
- 2012
Inflamed moods: A review of the interactions between inflammation and mood disorders
- Psychology, MedicineProgress in Neuro-Psychopharmacology and Biological Psychiatry
- 2014
The role of glutamate on the action of antidepressants
- Biology, PsychologyProgress in Neuro-Psychopharmacology and Biological Psychiatry
- 2011